Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRoger, Simon Den
dc.contributor.authorCrimmins, Denisen
dc.contributor.authorYiannikas, C.en
dc.contributor.authorHarris, D.C.en
dc.identifier.citationVolume 20, Issue 6, pp. 814-817en
dc.description.abstractTreatment of lead intoxication with intravenous ethylene-diamine-tetra-acetic acid (EDTA) depends on the urinary excretion of chelated lead. This route of excretion was absent in a 48-year-old patient with childhood lead exposure and end stage renal failure who developed encephalopathy and a rapidly progressive neuropathy thought to be due to acute lead intoxication. Diagnosis was confirmed by lead chelation with EDTA and neurophysiological studies. EDTA was added by the patient to her chronic ambulatory peritoneal dialysis (CAPD) fluid each week and chelated lead excreted in the dialysate. Intraperitoneal administration of EDTA was 70% as efficient in removing lead as intravenous administration. Four months of home chelation therapy was associated with resolution of the encephalopathy but no improvement in the peripheral neuropathy.en
dc.subjectKidney Diseaseen
dc.subjectDrug Therapyen
dc.titleLead Intoxication in an Anuric Patient: Management by Intraperitoneal EDTAen
dc.typeJournal Articleen
dc.identifier.journaltitleAustralian and New Zealand Journal of Medicineen
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
Appears in Collections:Renal Medicine
Show simple item record

Page view(s)

checked on Mar 24, 2023

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.